View Rule

FDA is proposing to amend its public information regulations. The proposed amendments bring the agency’s regulations in line with statutory amendments to the FOIA, update cross references to other statutes and parts of the agency’s regulations, and clarify certain provisions with minor editorial updates. Additionally, the rule will update the current regulations to reflect changes to the organization, to make the FOIA process easier for the public to navigate, and to make certain provisions clearer, such as the provisions regarding processing fees. Taken together, these changes will enhance transparency for the public with regard to FDA’s activities.